Redeye is positive about Paxman’s regulatory clearance in the EU and UK for its CIPN device.
Prisma visar fortsatt underliggande styrka trots hög expansionstakt.
Redeye comments on Lime’s Q2 report, beating on sales and EBITA thanks to strong Expert Services whi...
* Record quarterly sales: SEK 60m (+11% y-o-y), +9% vs.
Redeye sees a solid Q2 report from Vitec, showing robust overall sales growth and a 18% y/y growth i...
Duni Q2/26 came in below our estimate, with organic growth of -3% in line, but operating income of S...
Ahead of CapMan's Q2 2026 results on 8 August, we make slight revisions to our estimates, mainly to ...
* CRL questions SPARKLE endpoint analysis; re-read rejected *Ascelia disputes both points; expresses...
* Q2e: we expect Paper EBIT of ~PLN -20m * Pulp costs up following Suzano hikes * Fair value range o...
Redeye takes a positive view on 4C's Q2 report, which delivered a stronger-than-expected topline alo...
We maintain our estimates intact ahead of Fiskars' Q2 report.
Redeye comments on Magle's announcement of a binding restructuring agreement with the majority of it...
Redeye comments on Avensia’s sales figures for June and Q2, causing slight reductions of our sales a...
Q2 report out on 17 July Q2e sales of SEK 228m, flat y-o-y; EBIT adj.
Hyresintäkterna låg i nivå med föregående år på 30,7 meur för det första halvåret och uthyrningsgrad...
Redeye comments on the publication of the Complete Response Letter and Ascelia's subsequent press re...
Redeye updates on Invisio ahead of Q2-results (due 17 July) where we expect a sequential improvement...
Efter år av tunga förluster har Storytel framgångsrikt skiftat fokus mot lönsamhet.
Redeye expects a stable Q2 2026 report from Addnode, with a clearly negative headline in Design Mana...
* A stable quarter with solid EBITDA * One step back at Sainsbury's, a leap into the US * Fair value...